Day F - Search Results

1

Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease.

Day F, Sridharan S, Johnson C, Quah GT, Mallesara G, Kumar M, Poulter AL, Morrison A, van der Westhuizen A, Fraser A, Oldmeadow C, Martin J. Day F, et al. Asia Pac J Clin Oncol. 2024 Mar 21. doi: 10.1111/ajco.14057. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38512856

2

Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).

Day F, Sridharan S, Lynam J, Gedye C, Johnson C, Fraser A, Thompson SR, Michael M, Leong T, Roy A, Kumar M, van der Westhuizen A, Quah GT, Mandaliya H, Mallesara G, Sappiatzer J, Oldmeadow C, Martin J. Day F, et al. BMC Cancer. 2022 Dec 17;22(1):1324. doi: 10.1186/s12885-022-10407-8. BMC Cancer. 2022. PMID: 36528772 Free PMC article. Clinical Trial.

3

Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer.

Fraser A, Odelli C, Britton B, Kumar M, Day F, Tieu MT, Wratten C. Fraser A, et al. Among authors: day f. Asia Pac J Clin Oncol. 2020 Oct;16(5):e198-e206. doi: 10.1111/ajco.13342. Epub 2020 Jun 9. Asia Pac J Clin Oncol. 2020. PMID: 32519509

4

Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer.

Sridharan S, Day F, Loh J, Lynam J, Smart J, Holt B, Mandaliya H, Bonaventura A, Kumar M, Martin J. Sridharan S, et al. Among authors: day f. Radiat Oncol. 2022 Sep 14;17(1):158. doi: 10.1186/s13014-022-02127-x. Radiat Oncol. 2022. PMID: 36104707 Free PMC article. Clinical Trial.

5

Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists.

Day FL, Sherwood E, Chen TY, Barbouttis M, Varlow M, Martin J, Weber M, Sitas F, Paul C. Day FL, et al. Asia Pac J Clin Oncol. 2018 Dec;14(6):431-438. doi: 10.1111/ajco.12876. Epub 2018 Apr 29. Asia Pac J Clin Oncol. 2018. PMID: 29706029

6

Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy.

Day F, Kumar M, Fenton L, Gedye C. Day F, et al. J Immunother. 2017 Jan;40(1):36-38. doi: 10.1097/CJI.0000000000000146. J Immunother. 2017. PMID: 27684455

7

Business as unusual: medical oncology services adapt and deliver during COVID-19.

Travers A, Adler K, Blanchard G, Bonaventura T, Charlton J, Day F, Healey L, Kim S, Lombard J, Mallesara G, Mandaliya H, Navani V, Nordman I, Paterson R, Plowman L, Quah GT, Scalley M, Shrestha P, Tailor B, van der Westhuizen A, Zhang B, Gedye C, Lynam J. Travers A, et al. Among authors: day f. Intern Med J. 2021 May;51(5):673-681. doi: 10.1111/imj.15217. Intern Med J. 2021. PMID: 34047023 Free PMC article.

8

Changes in medical oncology admissions for the management of breast cancer complications: an Australian institution's experience.

Day FL, Bull JM, Lombard JM, Stewart JF. Day FL, et al. Asia Pac J Clin Oncol. 2011 Jun;7(2):146-53. doi: 10.1111/j.1743-7563.2011.01391.x. Asia Pac J Clin Oncol. 2011. PMID: 21585694

9

Implementing Smoking Cessation Interventions for Tobacco Users Within Oncology Settings: A Systematic Review.

Young AL, Stefanovska E, Paul C, McCarter K, McEnallay M, Tait J, Vinod S, White K, Day F, Stone E. Young AL, et al. Among authors: day f. JAMA Oncol. 2023 Jul 1;9(7):981-1000. doi: 10.1001/jamaoncol.2023.0031. JAMA Oncol. 2023. PMID: 37103911

10

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

McLean LS, Lim AM, Bressel M, Lee J, Ladwa R, Guminski AD, Hughes B, Bowyer S, Briscoe K, Harris S, Kukard C, Zielinski R, Alamgeer M, Carlino M, Mo J, Park JJ, Khattak MA, Day F, Rischin D. McLean LS, et al. Among authors: day f. Med J Aust. 2024 Feb 5;220(2):80-90. doi: 10.5694/mja2.52199. Epub 2024 Jan 11. Med J Aust. 2024. PMID: 38212673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page